Tanzanian Drug Treatment as AIDS Prevention - Reliability and Validity Study

坦桑尼亚药物治疗作为艾滋病预防 - 可靠性和有效性研究

基本信息

项目摘要

DESCRIPTION (provided by applicant): The purpose of this study, the Tanzanian Drug Treatment as HIV/AIDS Prevention Project (D-TAPP) - Reliability and Validity Study, is to conduct formative research necessary to the implement of drug treatment as an HIV prevention intervention in Dar es Salaam, Tanzania. The specific aims of D-TAPP 1) - Reliability and Validity Study are: Aim1: To develop culturally appropriate measures of psychological functioning, social functioning, treatment motivation, addiction severity, and readiness for treatment; Aim 2: To assess IDUs' understanding and relevancy of the measures of psychological functioning, social functioning, treatment motivation, addiction severity, and readiness for treatment; and Aim 3: To test the reliability and validity of the D-TAPP Questionnaire. The D-TAPP - Reliability and Validity Study will be implemented in three components reflecting the three specific aims using a mixed methods design. In component 1, the D-TAPP questionnaire will be translated from English to Swahili and the accuracy of the translations and the content validity of the translated measures will be assessed by a panel of native Swahili-speaking experts. In component 2, semi-structured interview data will be collected from a purposeful sample of 40 IDUs. In this component, the D-TAPP questionnaire will be presented to IDU participants, and they will be asked to assess the understandability and cultural relevancy of each item in the questionnaire (Aim 2). Participants will also be asked to evaluate scales used to record measurement responses. In particular, IDUs will be asked to make recommendations that will improve understandability, cultural relevancy, and response measurement. The questionnaire will be modified to reflect findings produced by the Component 2 study. Component 3 will assess the psychometrics of the measures. Internal and 48 hour test/retest reliability will be determined along with content, construct and criterion related validities. For this study, a purposeful sample of 150 IDUs will be recruited to participate. Data will be collected at intake and 48 hours later. PUBLIC HEALTH RELEVANCE: Tanzanian Drug Treatment as HIV/AIDS Prevention Project (D-TAPP) - Reliability and Validity Study will investigate the psychometric properties of standardized measures of treatment motivation in a sample of Tanzanian injection drug users.
描述(由申请人提供):坦桑尼亚药物治疗作为艾滋病毒/艾滋病预防项目(D-TAPP)——可靠性和有效性研究的目的是进行必要的形成性研究,以在坦桑尼亚达累斯萨拉姆实施药物治疗作为艾滋病毒预防干预措施。 D-TAPP 1) - 可靠性和有效性研究的具体目标是: 目标 1:针对心理功能、社会功能、治疗动机、成瘾严重程度和治疗准备情况制定适合文化的衡量标准;目标 2:评估吸毒者对心理功能、社会功能、治疗动机、成瘾严重程度和治疗准备程度等指标的理解和相关性;目标 3:测试 D-TAPP 问卷的信度和效度。 D-TAPP - 可靠性和有效性研究将通过三个部分实施,反映使用混合方法设计的三个具体目标。在第 1 部分中,D-TAPP 调查问卷将从英语翻译成斯瓦希里语,翻译的准确性和翻译措施的内容有效性将由斯瓦希里语母语专家小组进行评估。在第 2 部分中,将从 40 名注射吸毒者的有目的样本中收集半结构化访谈数据。在此部分中,将向 IDU 参与者提交 D-TAPP 调查问卷,并要求他们评估调查问卷中每个项目的可理解性和文化相关性(目标 2)。参与者还将被要求评估用于记录测量反应的量表。特别是,注射吸毒者将被要求提出建议,以提高可理解性、文化相关性和反应衡量。调查问卷将进行修改,以反映第 2 部分研究的结果。第 3 部分将评估这些措施的心理测量。内部和 48 小时测试/重新测试的可靠性将与内容、结构和标准相关的有效性一起确定。本研究将有目的地招募 150 名注射吸毒者作为样本参与。数据将在摄入时和 48 小时后收集。公共健康相关性:坦桑尼亚药物治疗作为艾滋病毒/艾滋病预防项目(D-TAPP)——可靠性和有效性研究将调查坦桑尼亚注射吸毒者样本中治疗动机标准化测量的心理测量特性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark L Williams其他文献

Mark L Williams的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark L Williams', 18)}}的其他基金

Investigator Development Core
研究者开发核心
  • 批准号:
    10436490
  • 财政年份:
    2021
  • 资助金额:
    $ 20.31万
  • 项目类别:
Investigator Development Core
研究者开发核心
  • 批准号:
    10494200
  • 财政年份:
    2021
  • 资助金额:
    $ 20.31万
  • 项目类别:
Investigator Development Core
研究者开发核心
  • 批准号:
    10657711
  • 财政年份:
    2021
  • 资助金额:
    $ 20.31万
  • 项目类别:
Tanzanian Drug Treatment as AIDS Prevention - Reliability and Validity Study
坦桑尼亚药物治疗作为艾滋病预防 - 可靠性和有效性研究
  • 批准号:
    8300392
  • 财政年份:
    2009
  • 资助金额:
    $ 20.31万
  • 项目类别:
EFFECT OF UREMIC GLUCOSE INTOLERANCE ON AGE'S & AGE LEVELS W/ VASCULAR DISEASE
尿毒症葡萄糖不耐受对年龄的影响
  • 批准号:
    7205223
  • 财政年份:
    2005
  • 资助金额:
    $ 20.31万
  • 项目类别:
Tanzania Injection Drug Use/HIV Prevention Project
坦桑尼亚注射吸毒/艾滋病毒预防项目
  • 批准号:
    6892578
  • 财政年份:
    2005
  • 资助金额:
    $ 20.31万
  • 项目类别:
Tanzania Injection Drug Use/HIV Prevention Project
坦桑尼亚注射吸毒/艾滋病毒预防项目
  • 批准号:
    7022979
  • 财政年份:
    2005
  • 资助金额:
    $ 20.31万
  • 项目类别:
Positive Choices Research Project
积极选择研究项目
  • 批准号:
    7064865
  • 财政年份:
    2003
  • 资助金额:
    $ 20.31万
  • 项目类别:
Positive Choices Research Project
积极选择研究项目
  • 批准号:
    7234458
  • 财政年份:
    2003
  • 资助金额:
    $ 20.31万
  • 项目类别:
Positive Choices Research Project
积极选择研究项目
  • 批准号:
    6591103
  • 财政年份:
    2003
  • 资助金额:
    $ 20.31万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了